Literature DB >> 30266249

Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years.

Riccardo Tellini1, Alessandro Antonelli2, Regina Tardanico3, Simona Fisogni3, Alessandro Veccia2, Maria Chiara Furlan2, Francesca Carobbio2, Alberto Cozzoli2, Tiziano Zanotelli2, Claudio Simeone2.   

Abstract

BACKGROUND: The role of positive surgical margins (PSMs) on the recurrence of renal cell carcinoma (RCC) after partial nephrectomy (PN) is debated, and available evidence lacks long-term data. The aim of this study was to evaluate the predictive role of PSMs on progression-free survival (PFS) in a large cohort followed for at least 5 years.
METHODS: This study was a retrospective analysis of a prospectively compiled single-institution database collecting complete information on more than 2700 patients who had undergone surgery for renal tumor. The data of all the patients submitted to PN for RCC and with least 5 years follow-up were extracted. Surgical specimens were examined at the time of surgery only by 2 expert uro-pathologists. A PSM was defined as the presence of cancer cells at the inked surface of the specimen. The role of PSMs on survival was estimated by Cox regression models adjusted for influent covariates.
RESULTS: A total of 459 patients fulfilled the inclusion criteria and were evaluated. PSMs were observed in 27 (5.9%) cases. No differences in preoperative and pathologic data were found comparing patients with and without PSMs. At a median follow-up of 96 months (interquartile range, 74-131 months), a clinically evident relapse of RCC was diagnosed in 36 (7.8%) patients at a median interval of 36 months from PN. Among these, 6 had a PSM for an incidence of relapse of 22.2% in the PSM group, whereas 30 had negative margins, for an incidence of 6.9% (P = .013). The sites of relapse were distant organs in 18 cases, and the kidney underwent PN in 21. The patients with PSMs showed a borderline significantly higher incidence of distant metastasis (11.1% vs. 3.5%; P = .071) and a significantly higher incidence of renal relapses (14.8% vs. 3.9%; P = .029). Multivariable Cox models confirmed that the presence of PSMs was an independent predictor of PFS (odds ratio, 3.127; P = .013).
CONCLUSIONS: PSMs are an independent predictor of PFS in patients who underwent PN for RCC, owing to a higher incidence of distant and local relapses. Surveillance in presence of PSMs should be intensified and extended for a long time.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Partial nephrectomy; Predictors; Prognosis; Recurrence; Renal Cell Carcinoma

Mesh:

Year:  2018        PMID: 30266249     DOI: 10.1016/j.clgc.2018.08.004

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


  7 in total

1.  MiR-186 represses progression of renal cell cancer by directly targeting CDK6.

Authors:  Zhen Guo; Xianbao Lv; Haiyan Jia
Journal:  Hum Cell       Date:  2020-04-07       Impact factor: 4.174

2.  Solitary, Late Metastatic Recurrence of Renal Cell Carcinoma to the Pancreas: A Case Report.

Authors:  Khalil Choucair; Nathaniel A Parker; Ammar Al-Obaidi; Joel Alderson; Phu Truong
Journal:  Cureus       Date:  2020-06-09

3.  Positive surgical margins may not affect the survival of patients with renal cell carcinoma after partial nephrectomy: A meta-analysis based on 39 studies.

Authors:  Renran Bai; Liang Gao; Jiawu Wang; Qing Jiang
Journal:  Front Oncol       Date:  2022-08-10       Impact factor: 5.738

Review 4.  Surgical margins after partial nephrectomy as prognostic factor for the risk of local recurrence in pT1 RCC: a systematic review and narrative synthesis.

Authors:  Michaël M E L Henderickx; Suraj V Baldew; Axel Bex; Patricia J Zondervan; Lorenzo Marconi; Marcel D van Dijk; Faridi S van Etten-Jamaludin; Brunolf W Lagerveld
Journal:  World J Urol       Date:  2022-05-03       Impact factor: 3.661

5.  Oncological Outcomes of Patients With Different Pathological Features of pT3a Renal Tumor: A Systematic Review and Quantitative Synthesis.

Authors:  Pengju Guo; Yongxing Wang; Yili Han; Dechao Wei; Jiahui Zhao; Mingchuan Li; Yongguang Jiang; Yong Luo
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

6.  The Clinicopathological Risk Factors in Renal Cell Cancer for the Oncological Outcomes Following Nephron-Sparing Surgery: A PRISMA Systematic Review and Meta-Analysis.

Authors:  Lijin Zhang; Bin Wu; Zhenlei Zha; Wei Qu; Hu Zhao; Jun Yuan
Journal:  Front Oncol       Date:  2020-03-06       Impact factor: 6.244

7.  Laparoscopic Versus Open Partial Nephrectomy: A Systemic Review and Meta-Analysis of Surgical, Oncological, and Functional Outcomes.

Authors:  Chengyu You; Yuelin Du; Hui Wang; Lei Peng; Tangqiang Wei; Xiaojun Zhang; Xianhui Li; Anguo Wang
Journal:  Front Oncol       Date:  2020-10-29       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.